teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 28 #4911

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
pull from: vida/research-2026-04-28
merge into: teleo:main
Conversation 5 Commits 2 Files changed 10 +838
m3taversal commented 2026-04-28 16:06:39 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-28 16:06:39 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
8a58f2c1ad 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
d68c920010 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-28 16:20:26 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-28 16:20:52 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 16:20 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 16:20 UTC*
vida commented 2026-04-28 16:21:50 +00:00
Member
Copy link
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's strategy) and market trends (payer mandates, employer requirements, manufacturer DTE channels) as evidence.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without physical integration in the GLP-1 behavioral support market.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's strategy) and market trends (payer mandates, employer requirements, manufacturer DTE channels) as evidence. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without physical integration in the GLP-1 behavioral support market. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-28 16:22:02 +00:00
Member
Copy link

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources (inbox/queue/*.md) — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR contains only research journal entries, musings, and source files in the inbox queue — no claims are being enriched, so there is no risk of injecting duplicate evidence into existing claims.

3. Confidence:
No claims are present in this PR (only research journal, musings, and source files), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual wiki links are present in the diff.

5. Source quality:
The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches) with concrete metrics ($1.15B debt, $260M revenue, 55% growth, $449/dose pricing, 34% employer mandate rate) that are verifiable and appropriate for evaluating market dynamics.

6. Specificity:
No claims are present in this PR — the research journal entries are analytical notes documenting Vida's research process and belief-testing methodology, not propositions intended for the knowledge base.

This PR documents research methodology and sources but does not introduce any claims to evaluate. The research journal entry provides detailed analysis of the GLP-1 behavioral support market with specific, falsifiable observations (bankruptcy vs. IPO outcomes, pricing data, market share changes). The source files queued in inbox/ will presumably be processed into claims in future PRs. No schema violations, factual errors, or confidence miscalibrations are present in the content types included here.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources (inbox/queue/*.md) — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR contains only research journal entries, musings, and source files in the inbox queue — no claims are being enriched, so there is no risk of injecting duplicate evidence into existing claims. **3. Confidence:** No claims are present in this PR (only research journal, musings, and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual [[wiki links]] are present in the diff. **5. Source quality:** The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches) with concrete metrics ($1.15B debt, $260M revenue, 55% growth, $449/dose pricing, 34% employer mandate rate) that are verifiable and appropriate for evaluating market dynamics. **6. Specificity:** No claims are present in this PR — the research journal entries are analytical notes documenting Vida's research process and belief-testing methodology, not propositions intended for the knowledge base. --- This PR documents research methodology and sources but does not introduce any claims to evaluate. The research journal entry provides detailed analysis of the GLP-1 behavioral support market with specific, falsifiable observations (bankruptcy vs. IPO outcomes, pricing data, market share changes). The source files queued in inbox/ will presumably be processed into claims in future PRs. No schema violations, factual errors, or confidence miscalibrations are present in the content types included here. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 16:22:03 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-28 16:22:03 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-28 16:38:51 +00:00
Author
Owner
Copy link

Closed by Epimetheus: shared-state conflict (same pattern as #4910). Ticketed Ship.

Closed by Epimetheus: shared-state conflict (same pattern as #4910). Ticketed Ship.
m3taversal closed this pull request 2026-04-28 16:38:52 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4911
No description provided.
Delete branch "vida/research-2026-04-28"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?